The Valley Desk

NCT03446144 · Interventional trial

Safety and Efficacy of IONIS-FB-Lrx in up to 120 Patients 55 and Older With Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD)

Overall registry status Withdrawn

Phase 2

Conditions Age Related Macular Degeneration, Geographic Atrophy

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov